Menarini Biotech | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,585 results for “Menarini Biotech”

ERBC and Menarini Biotech Form Strategic Alliance to Accelerate Biopharmaceutical Development

Medidata and Menarini Group Expand AI-Powered Partnership to Accelerate Oncology Clinical Trials

Menarini Group to Present Comprehensive Oncology Data at ASCO 2026, Featuring Elacestrant Combination Studies

Menarini Asia-Pacific to Commercialise Cosela (trilaciclib) Across Multiple APAC Markets, First Launch Anticipated in Hong Kong in 2028

Menarini Group to Present New ELZONRIS Data at ASH 2025, Including Promising Triplet Therapy Results for BPDCN

NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results

First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL

GenScript Biotech and NSG Bio Form Strategic Partnership to Accelerate Biotech Innovation in Singapore

BPGbio Named 2024 BioTech AI Company of the Year for AI-Driven Drug Discovery

NHS Rejects Elacestrant (Korserdu) for Advanced Breast Cancer with ESR1 Mutation

Page 1 of 345